Ability of Rabeprazole to Prevent Gastric Mucosal Damage From Clopidogrel and Low Doses of Aspirin Depends on CYP2C19 Genotype  Takahiro Uotani, Mitsushige.

Slides:



Advertisements
Similar presentations
Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.
Advertisements

Abnormal Liver Tests and Fatty Liver on Ultrasound
Saurabh Dawra, Vishal Sharma, Usha Dutta 
Ezekiel Wong Toh Yoon, Kazuki Nishihara 
Pichamol Jirapinyo, Christopher C. Thompson 
A Shocking Cystory Clinical Gastroenterology and Hepatology
Gastric Emptying Clinical Gastroenterology and Hepatology
Small Bowel Injury by Low-Dose Enteric-Coated Aspirin and Treatment With Misoprostol: A Pilot Study  Toshio Watanabe, Satoshi Sugimori, Natsuhiko Kameda,
Diffuse Gastric Wall Thickening: Appearances Can Be Deceptive
Judy A. Trieu, Mohammad Bilal, Ali Hashmi 
Use of Direct, Endoscopic-Guided Measurements of Mucosal Impedance in Diagnosis of Gastroesophageal Reflux Disease  Elif Saritas Yuksel, Tina Higginbotham,
Ampullary Carcinoid: Diagnostic Challenges and Update on Management
Tomislav Brkic, Mirjana Kalauz, Hrvoje Ivekovic 
Proximal Esophageal Varices: A Rare Yet Treatable Cause of Hemorrhage
Pancreatic Duct Drainage for the Treatment of a Huge Pancreatic Cyst Associated With Autoimmune Pancreatitis  Hiroyuki Matsubayashi, Toru Matsui, Hiroyuki.
Atif Saleem, David H. Bruining, Todd H. Baron 
Activity-Based Costing and Management in a Hospital-Based GI Unit
May Min, Jason Ferreira, Charles Wang 
Endoscopic Therapy for Barrett's Esophagus
Traveling Internationally: Avoiding and Treating Travelers' Diarrhea
Amie L. Harvey, Tommy Yen, Anand Kunda 
Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea  Reginald V. Fant,
Patrick Hoversten, Fouad Otaki, David A. Katzka 
Novel Endoscopic Therapeutics for Early Gastric Cancer
Miho Sakumura, Kazuto Tajiri, Toshiro Sugiyama 
Abnormal Liver Tests and Fatty Liver on Ultrasound
Thurarshen Jeyalingam, Yuto Shimamura, Christopher Teshima 
Gastroenterology in a New Era of Accountability: Part 2
Reduced Hospitalization Cost for Upper Gastrointestinal Events That Occur Among Elderly Veterans Who Are Gastroprotected  Neena S. Abraham, Christine.
New Models of Gastroenterology Practice
The Glasgow Blatchford Score Is the Most Accurate Assessment of Patients With Upper Gastrointestinal Hemorrhage  Stig Borbjerg Laursen, Jane Møller Hansen,
What Is the Prevalence of Clinically Significant Endoscopic Findings in Subjects With Dyspepsia? Systematic Review and Meta-analysis  Alexander C. Ford,
Intragastric Fistula After Multiple Sphere Magnet Ingestion
Peter Bytzer  Clinical Gastroenterology and Hepatology 
Harpal S. Dhaliwal, Saroj K. Sinha, Rakesh Kochhar 
Jagpal S. Klair, Mohit Girotra, Rayburn F. Rego 
A Young Woman With Gallstone Pancreatitis and Abnormal Liver Tests: When Is Endoscopic Retrograde Cholangiopancreatography Needed?  Andrew D. Rhim, Michael.
Issue Highlights Clinical Gastroenterology and Hepatology
Terumi Kamisawa, Naoko Kubota, Tomomi Okamoto 
Tamir Ben–Menachem, Jason A. Dominitz 
The Utility of Intraluminal Impedance in Patients With Gastroesophageal Reflux Disease–Like Symptoms But Normal Endoscopy and 24-Hour pH Testing  Michael.
Ashwin N. Ananthakrishnan, Emily L. McGinley, Kia Saeian 
Endoscopic Ultrasound and Endoscopic Mucosal Resection Features of a Non–Protein Losing Form of Ménétrier's Disease  Ferga C. Gleeson, Thomas F. Mangan,
Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet 
Rosanne M. Furse, Caroline J. Green, Anthony S. Mee 
Unusual Cause of Fever and Abdominal Pain: Acute Suppuration of the Pancreas Duct and Endoscopic Management  Robert Hirten, Divyesh V. Sejpal, Arvind.
Issue Highlights Clinical Gastroenterology and Hepatology
Hepatic Cyst? Clinical Gastroenterology and Hepatology
Predictors of Early Treatment Discontinuation Among Patients With Genotype 1 Hepatitis C and Implications for Viral Eradication  Lauren A. Beste, George.
Prevention of Gastric Volvulus-induced Recurrent Acute Pancreatitis by Percutaneous Endoscopic Gastropexy  Mitsuhiro Nikaido, Shin’ichi Miyamoto, Shoji.
Influence of CYP2C19 Polymorphism and Helicobacter pylori Genotype Determined From Gastric Tissue Samples on Response to Triple Therapy for H pylori Infection 
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Abdominal Aortitis Associated With Autoimmune Pancreatitis
Minimal-Change Esophagitis on Narrow-Band Imaging
Eric M. Nelsen, Darya Buehler, Patrick R. Pfau 
Coagulation in Liver Disease: A Guide for the Clinician
Hairball in the Stomach: A Case of Gastric Trichobezoar
Endoscopic Therapy of Jejunal Diphyllobothrium nihonkaiense Infection
Chun-Hua Zhou, Wei-Xia Zhou, Duan-Min Hu 
Preeth Jayaram, Alex Shindel, James Buxbaum 
Coloduodenal Fistula in Crohn’s Disease
Rintaro Hashimoto, Akimichi Chonan 
Adverse Outcomes: Why Bad Things Happen to Good People
Medical Therapy for Refractory Pediatric Crohn’s Disease
M. Babitha Reddy, David M. Poppers, Cora Uram–Tuculescu 
Issue Highlights Clinical Gastroenterology and Hepatology
Rintaro Hashimoto, Akimichi Chonan 
Subcapsular Hepatic Fluid Collection Caused by Cardiac Dysfunction
Klaus Mönkemüller, Helmut Neumann, Lucia C. Fry 
Choosing Wisely and the Perceived Drivers of Endoscopy Use
Presentation transcript:

Ability of Rabeprazole to Prevent Gastric Mucosal Damage From Clopidogrel and Low Doses of Aspirin Depends on CYP2C19 Genotype  Takahiro Uotani, Mitsushige Sugimoto, Masafumi Nishino, Chise Kodaira, Mihoko Yamade, Shu Sahara, Takanori Yamada, Satoshi Osawa, Ken Sugimoto, Tatsuo Tanaka, Kazuo Umemura, Hiroshi Watanabe, Hiroaki Miyajima, Takahisa Furuta  Clinical Gastroenterology and Hepatology  Volume 10, Issue 8, Pages 879-885.e2 (August 2012) DOI: 10.1016/j.cgh.2012.04.016 Copyright © 2012 AGA Institute Terms and Conditions

Figure 1 MLS system of gastric mucosal damage on days 3 and 7 in controls and the 4 treatment regimens in H pylori–negative (B) and –positive subjects (C) in study 1. (A) Representative endoscopic findings of gastric mucosal injury with different MLSs.15,16 (B) On days 3 and 7, significant gastric mucosal damages were observed with the A, C, and AC regimens in H pylori–negative subjects. For the ACR regimen, MLSs on days 3 and 7 were lowest apart from the controls. (C) On days 3 and 7, significant gastric mucosal damages were observed with the A, C, and AC regimens in H pylori–positive subjects. For the ACR regimen, the MLSs on days 3 and 7 were lowest apart from the controls. *P < .05. Clinical Gastroenterology and Hepatology 2012 10, 879-885.e2DOI: (10.1016/j.cgh.2012.04.016) Copyright © 2012 AGA Institute Terms and Conditions

Figure 2 Median 24-hour intragastric pH (A) and percent time with pH <4 (B) on day 7 in study 1. (A) The median 24-hour pH for the ACR regimen was significantly higher than those for other regimens (all P = .005), especially in H pylori–positive subjects. The 24-hour pH in regimen ACR was significantly higher in H pylori–positive subjects in comparison with that in H pylori–negative subjects. (B) The percentage time for pH <4 in the ACR regimen was significantly shorter than those for other regimens (all P = .005), especially in H pylori–positive subjects. The percentage time for pH <4 in regimen ACR was significantly shorter in H pylori–positive subjects in comparison with that in H pylori–negative subjects. *P < .05. Clinical Gastroenterology and Hepatology 2012 10, 879-885.e2DOI: (10.1016/j.cgh.2012.04.016) Copyright © 2012 AGA Institute Terms and Conditions

Figure 3 Effect of CYP2C19 genotype status (RM or IM/PM) on median 24-hour pH and gastric mucosal injury assessed by MLS with different regimens in H pylori–negative and –positive subjects in study 1. (A) The median pH in RMs was significantly lower than that in IM/PM groups with the ACR regimen in H pylori–negative subjects. (B) For the ACR regimen, the median MLS in RMs on day 7 was significantly higher than that in the IM/PM group in H pylori–negative subjects.*P < .05. Clinical Gastroenterology and Hepatology 2012 10, 879-885.e2DOI: (10.1016/j.cgh.2012.04.016) Copyright © 2012 AGA Institute Terms and Conditions

Figure 4 Ulcer/erosion-based (A) and hemorrhage-based (B) MLSs in control and 4 regimens on days 3 and 7. A significant increase in both ulcer/erosion and hemorrhage scores was observed in all of the regimens in comparison with controls on days 3 and 7. The ACR regimen significantly reduced hemorrhage score attained with the A, AC, and AC regimens. Although the A regimen increased both scores, the hemorrhage score in the C regimen was higher than that in ulcer/erosion score. *P < .05. Clinical Gastroenterology and Hepatology 2012 10, 879-885.e2DOI: (10.1016/j.cgh.2012.04.016) Copyright © 2012 AGA Institute Terms and Conditions

Figure 5 The effect of CYP2C19 genotype status on IPA by aspirin (A) and clopidogrel (B) and MLSs with AC regimen in study 2. (A) IPAs by aspirin increased from day 3 to day 7. IPAs by aspirin did not differ among CYP2C19 genotype groups. (B) IPA by clopidogrel significantly differed among the 3 CYP2C19 genotype groups. (C) MLS was increased from day 3 to day 7. However, MLSs did not differ among CYP2C19 genotype groups on days 3 and 7. *P < .05. Clinical Gastroenterology and Hepatology 2012 10, 879-885.e2DOI: (10.1016/j.cgh.2012.04.016) Copyright © 2012 AGA Institute Terms and Conditions